Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tapparelli

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|April 1, 1995
Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparinC Tapparelli, R Metternich, P Gfeller, et al.
Molecular Toxicology|January 1, 1987
Cyclosporine A nephrotoxicity studied by the combined application of kidney cell lines, hepatocytes, and endothelial-platelet coculturesA Vickers, J Guertler, C Spaans, et al.
Journal of the Neurological Sciences|October 1, 1989
Release of platelet Met-enkephalin, but not serotonin, in migraine. A platelet response unique to migraine patients?M D Ferrari, J Odink, M Frölich, et al.
Bioorganic & Medicinal Chemistry|October 12, 2000
Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding modeA von Matt, C Ehrhardt, P Burkhard, et al.
Biochemistry|June 4, 1996
Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesisB F Le Bonniec, T Myles, T Johnson, et al.
The Journal of Biological Chemistry|March 5, 1993
In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitorC Tapparelli, R Metternich, C Ehrhardt, et al.
Thrombosis and Haemostasis|September 1, 1993
Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonistsN S Cook, H G Zerwes, C Tapparelli, et al.
Neurology|September 1, 1989
Serotonin metabolism in migraineM D Ferrari, J Odink, C Tapparelli, et al.
Transgenic Research|May 11, 1992
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-IM E Swanson, T E Hughes, I S Denny, et al.
Journal of Lipid Research|December 1, 1989
Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by nonreducing gel electrophoresisD S France, T E Hughes, R Miserendino, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|April 1, 1995
Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparinC Tapparelli, R Metternich, P Gfeller, et al.
Molecular Toxicology|January 1, 1987
Cyclosporine A nephrotoxicity studied by the combined application of kidney cell lines, hepatocytes, and endothelial-platelet coculturesA Vickers, J Guertler, C Spaans, et al.
Journal of the Neurological Sciences|October 1, 1989
Release of platelet Met-enkephalin, but not serotonin, in migraine. A platelet response unique to migraine patients?M D Ferrari, J Odink, M Frölich, et al.
Bioorganic & Medicinal Chemistry|October 12, 2000
Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding modeA von Matt, C Ehrhardt, P Burkhard, et al.
Biochemistry|June 4, 1996
Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesisB F Le Bonniec, T Myles, T Johnson, et al.
The Journal of Biological Chemistry|March 5, 1993
In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitorC Tapparelli, R Metternich, C Ehrhardt, et al.
Thrombosis and Haemostasis|September 1, 1993
Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonistsN S Cook, H G Zerwes, C Tapparelli, et al.
Neurology|September 1, 1989
Serotonin metabolism in migraineM D Ferrari, J Odink, C Tapparelli, et al.
Transgenic Research|May 11, 1992
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-IM E Swanson, T E Hughes, I S Denny, et al.
Journal of Lipid Research|December 1, 1989
Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by nonreducing gel electrophoresisD S France, T E Hughes, R Miserendino, et al.
Pageof 3